20405154

Source:http://linkedlifedata.com/resource/pubmed/id/20405154

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005684, umls-concept:C0008838, umls-concept:C0025663, umls-concept:C0030797, umls-concept:C0031001, umls-concept:C0032854, umls-concept:C0035647, umls-concept:C0205281, umls-concept:C0205409, umls-concept:C1561558
pubmed:issue	5
pubmed:dateCreated	2010-10-8
pubmed:abstractText	Our aim was to evaluate the clinical significance of the negative-balance isolated pelvic perfusion (NIPP) method using ultrahigh-dose cisplatin (CDDP) for ten cases of invasive bladder cancer with poor risk such as high-grade cancer, advanced clinical stage, or appearance of hydronephrosis.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9616295
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1437-7772
pubmed:author	pubmed-author:KimataRyojiR, pubmed-author:KondoYukihiroY, pubmed-author:KumazakiTatsuoT, pubmed-author:MurataSatoruS, pubmed-author:NemotoKaoruK
pubmed:issnType	Electronic
pubmed:volume	15
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	433-9
pubmed:dateRevised	2011-9-13
pubmed:meshHeading	pubmed-meshheading:20405154-Aged, pubmed-meshheading:20405154-Antineoplastic Agents, pubmed-meshheading:20405154-Chemotherapy, Cancer, Regional Perfusion, pubmed-meshheading:20405154-Cisplatin, pubmed-meshheading:20405154-Female, pubmed-meshheading:20405154-Humans, pubmed-meshheading:20405154-Japan, pubmed-meshheading:20405154-Kaplan-Meier Estimate, pubmed-meshheading:20405154-Male, pubmed-meshheading:20405154-Middle Aged, pubmed-meshheading:20405154-Neoplasm Invasiveness, pubmed-meshheading:20405154-Neoplasm Staging, pubmed-meshheading:20405154-Pelvis, pubmed-meshheading:20405154-Prospective Studies, pubmed-meshheading:20405154-Risk Assessment, pubmed-meshheading:20405154-Risk Factors, pubmed-meshheading:20405154-Time Factors, pubmed-meshheading:20405154-Treatment Outcome, pubmed-meshheading:20405154-Urinary Bladder Neoplasms
pubmed:year	2010
pubmed:articleTitle	The negative-balance isolated pelvic perfusion method using ultrahigh-dose cisplatin for invasive bladder cancer with poor risk.
pubmed:affiliation	Department of Urology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan. s2027@nms.ac.jp
pubmed:publicationType	Journal Article